Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency

Haematologica

Volumn 93, Issue 6, 2008, Pages 934-938

  Karimi, Mehran ^a   Menegatti, Marzia ^b   Afrasiabi, Abdolreza ^a   Sarikhani, Sanaz ^a   Peyvandi, Flora ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bleeding disorders; Bleeding symptoms; F10; Factor X deficiency; Phenotype genotype

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENOTYPE; GINGIVA BLEEDING; HAPLOTYPE; HEMATOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDIA; IRAN; ITALY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; FACTOR X DEFICIENCY; FEMALE; GENES, RECESSIVE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 44949140390     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12211     Document Type: Article

References (24)

1. Bajaj SP, Mann KG. Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J Biol Chem 1973;248:7729-41.
2. Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry. 1986;25:5098-102.
3. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988;53:505-18.
4. Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci USA 1984;81:3699-702.
5. th ed. 2006. [updated 2007 Feb15]. Available from: http://www.med.unc.edu/isth/mutations-databases/FactorX_2006numbers.htm
6. Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S, et al. The Greifswald Factor X Deficiency Study Group. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor X gene. Haemophilia 2006;12:479-89.
7. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52.
8. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999;82:1207-14.
9. Peyvandi F, Menegatti M, Santagostino E, Akhavan S, Uprichard J, Perry DJ, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002;117:685-92.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
11. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5′ region of coagulation of factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993;90:575-6.
12. Pollak ES, Hung HL, Godin G, Overton GC, High KA. Functional characterization of the human factor VII 50 flanking region. J Biol Chem 1996;271:1738-47.
13. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991;11:540-6.
14. Miao CH, Leytus SP, Chung DW, Davie EW. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J Biol Chem 1992;11:7395-401.
15. Huang MN, Hung HL, Stanfield-Oakley SA, High KA. Characterization of the human blood coagulation factor X promoter. J Biol Chem 1992;267:1544-6.
16. Peyvandi F, Mannucci PM, Lak M, Abdoullahi M, Zeinali S, Sharifian, et al. Congenital factor X deficiency. Spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998;102:626-8.
17. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002;8:308-21.
18. Stanley TB, Jin D, Lin PJ, Stafford DW. The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase. J Biol Chem 1999;274:16940-4.
19. Ketterling RP, Vielhaber E, Bottema CDK, Schaid DJ, Cohen MP, Sexauer CL, et al. Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. Am J Hum Genet 1993;52:152-66.
20. Hewitt J, Ballard JN, Nelson TN, Smith VC, Griffiths TA, Pritchard S, et al. Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion. Br J Haematol 2005;128:380-5.
21. Watzke HH, Wallmark A, Hamaguchi N, Giardina P, Stafford DW, High KA. Factor X Santo Domingo, evidence that the severe clinical phenotype arises from a mutation blocking secretion. J Clin Invest 1991;88:1685-9.
22. Racchi M, Watzke HH, High KA, Lively MO. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 1993;268:5735-40.
23. Bereczky Z, Balogh I, Ajzner E, Kiss C, Komaromi I, Muszbek L. Molecular genetic analysis of an inherited factor X deficiency [abstract]. Haemostasis 2000;30:35.
24. Pinotti M, Camire RM, Baroni M, Rajab A, Marchetti G, Bernardi F. Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency. Thromb Haemost 2003;89:243-8.